tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

STRO Stock Latest News

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1
Press ReleasesSutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1
3d ago
STRO
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
Press ReleasesSutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
23d ago
STRO
Sutro Biopharma (STRO) Q1 Earnings Cheat Sheet
Pre-EarningsSutro Biopharma (STRO) Q1 Earnings Cheat Sheet
24d ago
STRO
Sutro Biopharma to Present at the JMP Securities Life Sciences Conference
Press ReleasesSutro Biopharma to Present at the JMP Securities Life Sciences Conference
30d ago
STRO
Sutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer
Press ReleasesSutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer
1M ago
STRO
Sutro Biopharma Presents Preclinical Data for its ROR1 Targeting Antibody Drug Conjugate STRO-003 at the AACR Annual Meeting 2023
Press ReleasesSutro Biopharma Presents Preclinical Data for its ROR1 Targeting Antibody Drug Conjugate STRO-003 at the AACR Annual Meeting 2023
2M ago
STRO
Sutro Biopharma price target lowered to $17 from $20 at JMP Securities
The FlySutro Biopharma price target lowered to $17 from $20 at JMP Securities
2M ago
STRO
Sutro Biopharma price target lowered to $16 from $20 at H.C. Wainwright
The FlySutro Biopharma price target lowered to $16 from $20 at H.C. Wainwright
2M ago
STRO
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
Press ReleasesSutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
2M ago
STRO
Sutro transferred with Equal Weight from Overweight at Wells Fargo
The FlySutro transferred with Equal Weight from Overweight at Wells Fargo
3M ago
IMGN
STRO
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesSutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
STRO
Sutro Biopharma appoints Borgman as Chief Medical Officer
The FlySutro Biopharma appoints Borgman as Chief Medical Officer
3M ago
JAZZ
STRO
Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer  
Press ReleasesSutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer  
3M ago
STRO
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesSutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4M ago
STRO
Sutro Biopharma price target raised to $25 from $21 at Truist
The FlySutro Biopharma price target raised to $25 from $21 at Truist
5M ago
STRO
Sutro Biopharma price target raised to $18 from $16 at Piper Sandler
The FlySutro Biopharma price target raised to $18 from $16 at Piper Sandler
5M ago
STRO
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer
Press ReleasesSutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer
5M ago
STRO
Sutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
Press ReleasesSutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
5M ago
STRO
Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer
Press ReleasesSutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer
6M ago
STRO
Sutro Biopharma, Vaxcyte in development option grant deal for cell-free extract
The FlySutro Biopharma, Vaxcyte in development option grant deal for cell-free extract
6M ago
PCVX
STRO
Sutro Biopharma and Vaxcyte Enter into Option Grant Agreement for the Development and Manufacturing Rights of Cell-Free Extract
Press ReleasesSutro Biopharma and Vaxcyte Enter into Option Grant Agreement for the Development and Manufacturing Rights of Cell-Free Extract
6M ago
STRO
Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022
Press ReleasesSutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022
6M ago
STRO